Product Images Aqneursa
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 3 images provide visual information about the product associated with Aqneursa NDC 83853-101 by Intrabio Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Carton label - Carton label
Figure section 11 - Figure section 11
Table 4 section 14 - Table 4 section 14
Table 4 provides a summary of the efficacy results for mSARA and SARA. The Modified Scale for the Assessment and Rating of Ataxia (mSARA) baseline value was 0.98 with a standard deviation of 0.05. The treatment effect of Brand Name versus Placebo was -0.96 with a standard deviation of 0.25. The total change versus baseline for Brand Name was -1.66. The Scale for the Assessment and Rating of Ataxia (SARA) baseline value was 0.95 with a standard deviation of 0.04. The treatment effect of Brand Name versus Placebo was -128 with a standard deviation of 0.31. The total change versus baseline for Brand Name was -1.97. For the placebo group, the total change versus baseline was -0.60. Please note that this description is based on the provided text and may contain errors or inaccuracies.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
